ESC Professional Premium Access

Biomarkers for heart failure 1

Event: ESC Congress 2022
Topic: Biomarkers
Session type: Moderated ePosters
Date: 27 August 2022
Time: 17:15 - 18:00

Congress Session

7 presentations in this session

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Speaker: Doctor O. Wozniak (Warsaw, PL)

Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Speaker: Doctor J. Cunningham (Boston, US)

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Speaker: Doctor M. Iguchi (Kyoto, JP)
Speaker: Professor K. Hasegawa (Kyoto, JP)

Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure

Speaker: Doctor R. Pistulli (Munster, DE)

Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).

Speaker: Mr C. Kelly (Newcastle, AU)

Protein signatures of heart failure mortality in the community

Speaker: Doctor K. Kuku (Washington DC, US)

8 speakers from this session

Doctor Roland Klingenberg

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)
0 follower

Doctor Olgierd Wozniak

National Institute of Cardiology, Warsaw (Poland)
0 follower

Doctor Jonathan Cunningham

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
0 follower

Doctor Moritake Iguchi

Kyoto Medical Centre, Kyoto (Japan)
0 follower

Professor Koji Hasegawa

National Hospital Organization Kyoto Medical Center, Kyoto (Japan)
1 presentation
0 follower

Doctor Rudin Pistulli

University Hospital of Munster, Munster (Germany)
0 follower

Mr Conagh Kelly

University of Newcastle, Newcastle (Australia)
0 follower

Doctor Kayode Kuku

MedStar Health Research Institute, Washington DC (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk